Articles citing this paper
Vaccination against oncogenic human papillomavirus infection in HIV-infected populations: review of current status and future perspectives
Lars Toft A B , Martin Tolstrup A , Merete Storgaard A , Lars Østergaard A and Ole S. Søgaard A
+ Author Affiliations
- Author Affiliations
A Department of Infectious Diseases, Aarhus University Hospital, Skejby, 8200 Aarhus, Denmark.
B Corresponding author. Email: larsnise@rm.dk
Sexual Health 11(6) 511-523 https://doi.org/10.1071/SH14015
Submitted: 14 January 2014 Accepted: 5 August 2014 Published: 9 September 2014
24 articles found in Crossref database.
Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines
Brotherton Julia M.L.,
Jit Mark,
Gravitt Patti E.,
Brisson Marc,
Kreimer Aimée R.,
Pai Sara I.,
Fakhry Carole,
Monsonego Joseph, Franceschi Silvia
International Journal of Cancer. 2016 139(3). p.510
Human papillomavirus DNA in men who have sex with men: type-specific prevalence, risk factors and implications for vaccination strategies
King E M,
Gilson R,
Beddows S,
Soldan K,
Panwar K,
Young C,
Prah P,
Jit M,
Edmunds W J, Sonnenberg P
British Journal of Cancer. 2015 112(9). p.1585
Comprehensive Human Papillomavirus Genotyping in Cervical Squamous Cell Carcinomas and Its Relevance to Cervical Cancer Prevention in Malawian Women
Howitt Brooke E.,
Herfs Michael,
Tomoka Tamiwe,
Kamiza Steve,
Gheit Tarik,
Tommasino Massimo,
Delvenne Philippe,
Crum Christopher P., Milner Danny
Journal of Global Oncology. 2017 3(3). p.227
Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of High-Grade Anal Intraepithelial Neoplasia in HIV+ Men
Gosens Karien C.M.,
van der Burg Sjoerd H.,
Welters Marij J.P.,
Boekestijn Sanne,
Loof Nikki M.,
Quint Wim G.V.,
van Noesel Carel J.M.,
van der Wal Allard C.,
Richel Olivier,
Krebber Wilhelmus J.T.A.,
Melief Cornelis J.M.,
de Vries Henry J.C., Prins Jan M.
Clinical Cancer Research. 2023 29(20). p.4109
Effectiveness of ‘catch-up’ human papillomavirus vaccination to prevent cervical neoplasia in immunosuppressed and non-immunosuppressed women
Silverberg Michael J.,
Leyden Wendy A.,
Lam Jennifer O.,
Chao Chun R.,
Gregorich Steven E.,
Huchko Megan J.,
Kulasingam Shalini,
Kuppermann Miriam,
Smith-McCune Karen K., Sawaya George F.
Vaccine. 2020 38(29). p.4520
HPV vaccination of immunocompromised hosts
Garland S.M.,
Brotherton J.M.L.,
Moscicki A.B.,
Kaufmann A.M.,
Stanley M.,
Bhatla N.,
Sankaranarayanan R.,
de Sanjosé S., Palefsky J.M.
Papillomavirus Research. 2017 4 p.35
Pathobiology of human papillomaviruses in human immunodeficiency virus – Infected persons
Krishnamurti Uma, Unger Elizabeth R.
Seminars in Diagnostic Pathology. 2017 34(4). p.364
Human Papillomavirus-Related Cancer Surveillance, Prevention, and Screening Among Transgender Men and Women: Neglected Populations at High Risk
Brown Brandon,
Poteat Tonia,
Marg Logan, Galea Jerome T.
LGBT Health. 2017 4(5). p.315
A systematic review of immunogenicity, clinical efficacy and safety of human papillomavirus vaccines in people living with the human immunodeficiency virus
Mavundza Edison J.,
Wiyeh Alison B.,
Mahasha Phetole W.,
Halle-Ekane Gregory, Wiysonge Charles S.
Human Vaccines & Immunotherapeutics. 2020 16(2). p.426
Immunogenicity and safety of the human papillomavirus vaccine in patients with autoimmune diseases: A systematic review
Pellegrino Paolo,
Radice Sonia, Clementi Emilio
Vaccine. 2015 33(30). p.3444
HPV vaccination in Southern Africa: A jab of hope in the fight against cervical cancer
Michelow Pamela, Firnhaber Cynthia
Cancer Cytopathology. 2016 124(10). p.695
Neoplasia and Precursor Lesions of the Female Genital Tract in IBD: Epidemiology, Role of Immunosuppressants, and Clinical Implications
Hazenberg Hanna M J L,
de Boer Nanne K H,
Mulder Chris J J,
Mom Stijn H,
van Bodegraven Ad A, Tack Greetje J
Inflammatory Bowel Diseases. 2018 24(3). p.510
HIV-associated malignancies in children
Singh Elvira,
Naidu Gita,
Davies Mary-Ann, Bohlius Julia
Current Opinion in HIV and AIDS. 2017 12(1). p.77
Brief Report: Antibody Responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay
Kahn Jessica A.,
Xu Jiahong,
Kapogiannis Bill G., Sleasman John W.
JAIDS Journal of Acquired Immune Deficiency Syndromes. 2017 75(2). p.241
A case study and proposal for publishing directed acyclic graphs: The effectiveness of the quadrivalent human papillomavirus vaccine in perinatally HIV Infected girls
Barnard-Mayers Ruby,
Kouser Hiba,
Cohen Jamie A.,
Tassiopoulos Katherine,
Caniglia Ellen C.,
Moscicki Anna-Barbara,
Campos Nicole G.,
Caunca Michelle R.,
Seage George R. Seage, Murray Eleanor J
Journal of Clinical Epidemiology. 2022 144 p.127
Prevention and control of neoplasms associated with HPV in high-risk groups in Mexico City: The Condesa Study
Lazcano-Ponce Eduardo,
Salmerón Jorge,
González Andrea,
Allen-Leigh Betania,
León-Maldonado Leith,
Magis Carlos,
Aranda-Flores Carlos,
Conde-González Carlos,
Portillo-Romero Alejandra Jalil,
Yunes-Díaz Elsa,
Rivera-Rivera Leonor,
Vargas Galileo,
Nyitray Alan G., Giuliano Anna R
Salud Pública de México. 2018 60(6, nov-dic). p.703
High-risk HPV genotypes in Zimbabwean women with cervical cancer: Comparative analyses between HIV-negative and HIV-positive women
Kuguyo Oppah,
Dube Mandishora Racheal S.,
Thomford Nicholas Ekow,
Makunike-Mutasa Rudo,
Nhachi Charles F. B.,
Matimba Alice,
Dandara Collet, Andrei Graciela
PLOS ONE. 2021 16(9). p.e0257324
Vaccines against human papillomavirus in low and middle income countries: a review of safety, immunogenicity and efficacy
Nakalembe Miriam,
Mirembe Florence M., Banura Cecily
Infectious Agents and Cancer. 2015 10(1).
High specific immune response to a bivalent anti-HPV vaccine in HIV-1-infected men in São Paulo, Brazil
Fontes Adriele,
Andreoli Maria Antonieta,
Villa Luisa Lina,
Assone Tatiane,
Gaester Karen,
Fonseca Luiz A.M.,
Duarte Alberto JS, Casseb Jorge
Papillomavirus Research. 2016 2 p.17
Estimating the effect of HIV on cervical cancer elimination in South Africa: Comparative modelling of the impact of vaccination and screening
Boily Marie-Claude,
Barnabas Ruanne V.,
Rönn Minttu M.,
Bayer Cara J.,
van Schalkwyk Cari,
Soni Nirali,
Rao Darcy W.,
Staadegaard Lisa,
Liu Gui,
Silhol Romain,
Brisson Marc,
Johnson Leigh F.,
Bloem Paul,
Gottlieb Sami,
Broutet Nathalie, Dalal Shona
eClinicalMedicine. 2022 54 p.101754
Anogenital warts in HIV-positive patients
Prozherin S.V., Podymova A.S.
Klinicheskaya dermatologiya i venerologiya. 2022 21(1). p.128
Four-year persistence of type-specific immunity after quadrivalent human papillomavirus vaccination in HIV-infected children: Effect of a fourth dose of vaccine
Levin Myron J.,
Huang Sharon,
Moscicki Anna-Barbara,
Song Lin-Ye,
Read Jennifer S.,
Meyer William A.,
Saah Alfred J.,
Richardson Kelly, Weinberg Adriana
Vaccine. 2017 35(13). p.1712
Prevalence of cervical, oral, and anal human papillomavirus infection in women living with HIV in Denmark – The SHADE cohort study
Thorsteinsson Kristina,
Storgaard Merete,
Katzenstein Terese L.,
Ladelund Steen,
Rönsholt Frederikke F,
Johansen Isik Somuncu,
Pedersen Gitte,
Gaardsting Anne,
Nielsen Lars Nørregård,
Bonde Jesper, Lebech Anne-Mette
Journal of Clinical Virology. 2018 105 p.64
Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis
Staadegaard Lisa,
Rönn Minttu M.,
Soni Nirali,
Bellerose Meghan E.,
Bloem Paul,
Brisson Marc,
Maheu-Giroux Mathieu,
Barnabas Ruanne V.,
Drolet Melanie,
Mayaud Philippe,
Dalal Shona, Boily Marie-Claude
eClinicalMedicine. 2022 52 p.101585
